However, those effects were reduced by treatment of GPX-1 mimetic ebselen, which confirms the crucial role of GPX-1–mediated antioxidant defence in the regulation of vascular inflammation and endothelial dysfunction in cardiovascular diseases [44]. The gene discussed is GPX1; the disease is endothelial dysfunction.